Preclinical validation of AVGN7 for treating duchenne muscular dystrophy
Ended Project Grant Awarded Last action
- Award ID
- R43AR075438
- Recipient
-
Aavogen Inc. UEI D7WBG8G7AWE4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,999
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,999 |
Quick answers
Who received award R43AR075438?
R43AR075438 was awarded to Aavogen Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 19, 2019.
How much is award R43AR075438 worth?
$224,999 has been obligated on R43AR075438.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award